Pricing Log in Create free account

Dare Bioscience, Inc. (DARE) vs Lipocine Inc. (LPCN)

Dare Bioscience, Inc. and Lipocine Inc. are both Biotechnology companies. Dare Bioscience, Inc. and Lipocine Inc. are of similar size ($12.6M and $12.3M). Dare Bioscience, Inc. grew revenue faster over the last twelve months: 7,817.5% against −13.4%. Lipocine Inc. has the higher net margin (−249.2% vs −804.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Lipocine Inc. leads on 11 and Dare Bioscience, Inc. on 4.

Valuation

Metric DARE LPCN Biotechnology median
P/E n/m n/m 10.60
P/S 6.98 3.46 9.40
P/B n/m 0.61 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.54 0.66
EV/Sales 3.86 (1.49) 9.02
Earnings yield (121.97%) (86.62%) (32.88%)
Free cash flow yield (121.75%) (78.12%) (23.13%)

Profitability

Metric DARE LPCN Biotechnology median
Gross margin 58.84% 100.00% 68.51%
Operating margin (813.35%) (269.05%) 0.00%
Net margin (804.33%) (249.16%) 0.00%
Free cash flow margin (849.36%) (267.37%) 0.00%
Return on equity 165.29% (52.86%) (51.96%)
Return on assets (62.16%) (47.52%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DARE LPCN Biotechnology median
Revenue growth (TTM) 7,817.51% (13.36%) 6.76%
EPS growth (last fiscal year) (150.00%) (93,988.89%) 29.88%
Revenue growth, 5-year CAGR 66.71% 64.32% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DARE LPCN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.99 11.36 4.97
Net debt to EBITDA 2.07 1.42 1.01

Dividend

Metric DARE LPCN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DARE LPCN Biotechnology median
Market cap 12.27m 12.61m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack